Altman Peter purchased $4K of BCDA
Altman Peter (President and CEO) purchased 5,000 shares of BioCardia, Inc. (BCDA) at $0.78 on 2026-07-29.
How this was made
The 30-second read
Why it matters
This is an insider open-market purchase by the CEO, but the disclosure does not include new company performance, guidance, or external events that would materially change valuation expectations.
Market read
Traders may note the insider buy as a small sentiment input, but it is not a standalone fundamental catalyst.
What to watch
The filing lacks any accompanying company-specific catalyst (guidance, trial results, financing, or regulatory updates), limiting tradable conclusions.
Background
The article is a primary-source SEC Form 4 insider transaction for BioCardia, Inc. (BCDA).
Ticker impact
BioCardia CEO Altman Peter filed a Form 4 open-market purchase of 5,000 shares at $0.7800 on 2026-07-29.
Likely limited immediate price impact; any effect would be sentiment-driven and short-lived.
Form 4 insider purchases can be read as confidence, but the article provides no new operational, financial, or regulatory catalyst, and the transaction size is modest relative to typical market-moving events.
Market effects
No sector-wide read-through is provided beyond a single-company insider transaction.
None indicated.
None indicated.
Counterpoint
Insider buys on Form 4 can reflect routine liquidity needs or diversification rather than a strong forward-looking signal, especially without a 10b5-1 plan context.
Key entities
- issuerBioCardia, Inc.
Subject of the Form 4 insider transaction; CEO Altman Peter purchased 5,000 shares at $0.7800 on 2026-07-29.
- insiderAltman Peter
President and CEO and reporting person on the Form 4; direct ownership purchase.
